6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Tyrosine Kinases ◽

Growth Factor Receptor ◽

Irreversible Inhibitors ◽

Her 2 ◽

ChemInform Abstract: 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity.

ChemInform ◽

10.1002/chin.200149115 ◽

2010 ◽

Vol 32 (49) ◽

pp. no-no

Author(s):

Hwei-Ru Tsou ◽

et al. et al.

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Tyrosine Kinases ◽

Growth Factor Receptor ◽

Irreversible Inhibitors ◽

Her 2 ◽

Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens

Cell Biochemistry and Biophysics ◽

10.1007/s12013-011-9286-1 ◽

2011 ◽

Vol 62 (1) ◽

pp. 221-228 ◽

Cited By ~ 68

Author(s):

Jiyuan Yang ◽

Hesheng Luo ◽

Yan Li ◽

Junchuan Li ◽

Zhiqiang Cai ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Diagnostic Tests ◽

Growth Factor Receptor ◽

Intratumoral Heterogeneity ◽

Her 2 ◽

Abstract 4562: Superior targeting of the human epidermal growth factor receptor 2 (HER-2) with recombinant monoclonal antibody mixtures

10.1158/1538-7445.am2011-4562 ◽

2011 ◽

Cited By ~ 3

Author(s):

Mikkel W. Pedersen ◽

Helle J. Jacobsen ◽

Thomas T. Poulsen ◽

Per J. Meijer ◽

Michael Kragh

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Recombinant Monoclonal Antibody ◽

Her 2 ◽

Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000853 ◽

2020 ◽

Vol 31 (3) ◽

pp. 241-250

Author(s):

Sei Shu ◽

Yoriko Yamashita-Kashima ◽

Mieko Yanagisawa ◽

Hayao Nakanishi ◽

Yasuhiro Kodera ◽

...

Keyword(s):

Gastric Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Xenograft Models ◽

Gastric Cancer Xenograft

Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer

Oncology Reports ◽

10.3892/or.18.2.433 ◽

2007 ◽

Cited By ~ 1

Author(s):

Hiroyuki Saeki ◽

Shunsuke Yanoma ◽

Shouji Takemiya ◽

Yukio Sugimasa ◽

Makoto Akaike ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Growth Factor Receptor ◽

Oral Fluoropyrimidine ◽

Korelasi Pemeriksaan Human Epidermal Growth Factor Receptor-2 (Her-2) dengan Stadium Klinis TNM pada Pasien Kanker Payudara di Instalasi Patologi Anatomi RS dr. Saiful Anwar Periode Januari 2010-Desember 2012

majalah kesehatan ◽

10.21776/ub.majalahkesehatan.003.03.1 ◽

2016 ◽

Vol 3 (3) ◽

pp. 112-120

Author(s):

Achmad Fahrur Rozi ◽

Rachmad Sarwo Bekti ◽

Jack Roebijoso

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Her 2 ◽

Clinicopathological Significance Of Human Epidermal Growth Factor Receptor- 2 (HER-2/Neu) Over-Expression In Gastric And Oesophageal Carcinomas Of Upper Gastrointestinal Biopsies

Annals of Pathology and Laboratory Medicine ◽

10.21276/apalm.2045 ◽

2018 ◽

Vol 5 (11) ◽

pp. A928-934

Author(s):

Lynda Dennis Rodrigues ◽

Surekha B Hippargi

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Over Expression ◽

Clinicopathological Significance ◽

Her 2 ◽

Epidermal Growth ◽

Upper Gastrointestinal

UJI AKTIVITAS ANTIKANKER PAYUDARA SENYAWA ANDROGRAFOLIDA DARI TUMBUHAN SAMBILOTO (Andrographis paniculata (Burm F) Ness.) TERHADAP HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER-2) SECARA IN SILICO

Jurnal Ilmiah Farmasi Farmasyifa ◽

10.29313/jiff.v4i2.7784 ◽

2021 ◽

Vol 4 (2) ◽

pp. 39-50

Author(s):

Sintya Suherlan ◽

Rohayah Rohayah ◽

Taufik Muhammad Fakih

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

In Silico ◽

Growth Factor Receptor ◽

Andrographis Paniculata ◽

Her 2 ◽

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER 2 oncogene alterations

Cancer Science ◽

10.1111/cas.12845 ◽

2015 ◽

Vol 107 (1) ◽

pp. 45-52 ◽

Cited By ~ 40

Author(s):

Ken Suzawa ◽

Shinichi Toyooka ◽

Masakiyo Sakaguchi ◽

Mizuki Morita ◽

Hiromasa Yamamoto ◽

...

Keyword(s):

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Effect ◽

Growth Factor Receptor ◽

Lung Cancers ◽

Her 2 ◽

Superior Antitumor Activity of a Novel Bispecific Antibody Cotargeting Human Epidermal Growth Factor Receptor 2 and Type I Insulin-like Growth Factor Receptor

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-13-0558 ◽

2013 ◽

Vol 13 (1) ◽

pp. 90-100 ◽

Cited By ~ 13

Author(s):

C. Chen ◽

Y. Zhang ◽

J. Li ◽

S. W. Tsao ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Bispecific Antibody ◽

Growth Factor Receptor ◽

Type I ◽

Insulin Like Growth Factor ◽